McHugh Jonathan B, Hoschar Aaron P, Dvorakova Mari, Parwani Anil V, Barnes E Leon, Seethala Raja R
Department of Pathology, University of Michigan Medical Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0054, USA.
Head Neck Pathol. 2007 Dec;1(2):123-31. doi: 10.1007/s12105-007-0031-4. Epub 2007 Oct 26.
Metastatic renal cell carcinoma (RCC) can pose diagnostic challenges in the head and neck often resembling benign and malignant oncocytic lesions. Immunohistochemical panels have been reported to help with this differential but are not entirely specific or sensitive. We have noticed that p63 routinely stains salivary gland oncocytomas but not metastatic RCC. Nineteen oncocytomas, 9 cases of oncocytosis, 9 oncocytic carcinomas and 16 head and neck metastatic RCC were studied. Morphologic features evaluated were cytoplasmic character (clear versus oncocytic), Fuhrman nuclear grade, mitotic rate, growth pattern, presence of lumens/blood lakes and stromal characteristics. Tumors were stained with antibodies to p63, renal cell carcinoma marker (RCCm), CD10, and vimentin. Eight benign oncocytic tumors (29%) had clear cell features while 6 metastatic RCC (37%) had oncocytic features. Median Fuhrman nuclear grade was 2 in oncocytoma and oncocytosis and 3 both oncocytic carcinoma and metastatic RCC. Mitotic rates were only significantly different between benign oncocytic tumors and metastatic RCC. All oncocytomas had lumina compared to half of metastatic RCC, all of which also demonstrated blood lakes. Seven benign oncocytic tumors (25%) and 5 oncocytic carcinomas (56%) had RCC-like vascular stroma. All primary salivary gland tumors were positive for p63, predominately in basal cell-type distribution. None of the metastatic RCC was positive. RCCm was entirely specific but lacked sensitivity for metastatic RCC while CD10 and vimentin showed variable sensitivity and specificity. While clinical history and morphology usually are adequate, demonstration of p63 staining can definitively exclude metastatic RCC from the differential diagnosis of similar appearing tumors in salivary glands, namely oncocytoma and oncocytic carcinoma, with 100% specificity and sensitivity. While RCCm, CD10, and vimentin performed adequately, they were significantly less reliable than p63 with both false positives and false negatives.
转移性肾细胞癌(RCC)在头颈部常可造成诊断难题,其表现常类似于良性和恶性嗜酸细胞瘤性病变。据报道,免疫组化检测有助于鉴别诊断,但并不完全特异或敏感。我们注意到,p63通常可使涎腺嗜酸细胞瘤着色,而转移性RCC不着色。本研究纳入了19例嗜酸细胞瘤、9例嗜酸细胞增多症、9例嗜酸细胞癌和16例头颈部转移性RCC。评估的形态学特征包括细胞质特征(透明细胞与嗜酸细胞)、Fuhrman核分级、有丝分裂率、生长方式、管腔/血湖的存在情况以及间质特征。肿瘤用p63、肾细胞癌标志物(RCCm)、CD10和波形蛋白抗体进行染色。8例良性嗜酸细胞瘤性肿瘤(29%)具有透明细胞特征,而6例转移性RCC(37%)具有嗜酸细胞特征。嗜酸细胞瘤和嗜酸细胞增多症的Fuhrman核分级中位数为2,嗜酸细胞癌和转移性RCC均为3。有丝分裂率仅在良性嗜酸细胞瘤性肿瘤与转移性RCC之间存在显著差异。所有嗜酸细胞瘤均有管腔,而转移性RCC有一半有管腔,所有转移性RCC也均有血湖。7例良性嗜酸细胞瘤性肿瘤(25%)和5例嗜酸细胞癌(56%)具有RCC样血管间质。所有原发性涎腺肿瘤p63均呈阳性,主要呈基底细胞型分布。转移性RCC均为阴性。RCCm完全特异,但对转移性RCC缺乏敏感性,而CD10和波形蛋白的敏感性和特异性各异。虽然临床病史和形态学通常就足够了,但p63染色可明确地将转移性RCC从涎腺中类似表现肿瘤(即嗜酸细胞瘤和嗜酸细胞癌)的鉴别诊断中排除,特异性和敏感性均为100%。虽然RCCm、CD10和波形蛋白表现尚可,但与p63相比,它们出现假阳性和假阴性的情况明显更不可靠。